128 related articles for article (PubMed ID: 845006)
1. Effect of estracyt on the rat prostate.
Yamanaka H; Shimazaki J; Imai K; Sugiyama Y; Shida K
Invest Urol; 1977 Mar; 14(5):400-4. PubMed ID: 845006
[TBL] [Abstract][Full Text] [Related]
2. Incorporation of 3H-thymidine and 14C-amino acids into the ventral prostate after in vivo treatment with estradiol-3N-BIS(2-chloroethyl)carbamate-17 beta-phosphate (Estracyt) and its estrogen and cytostatic parts.
Hoisaeter PA
Invest Urol; 1976 Sep; 14(2):85-92. PubMed ID: 972011
[TBL] [Abstract][Full Text] [Related]
3. Studies on the antiprostatic action of estracyt, a nitrogen mustard of estradiol.
Kirdani RY; Müntzing J; Varkarakis MJ; Murphy GP; Sandberg AA
Cancer Res; 1974 May; 34(5):1031-7. PubMed ID: 4823900
[No Abstract] [Full Text] [Related]
4. Effect of estrogen administration on activities of testosterone 5alpha-reductase, alkaline phosphatase and arginase in the ventral and the dorsolateral prostates of rats.
Yamanaka H; Shimazaki J; Imai K; Sugiyama Y; Shida K
Endocrinol Jpn; 1975 Aug; 22(4):297-302. PubMed ID: 1201739
[TBL] [Abstract][Full Text] [Related]
5. Effect of drug-vinyl copolymer delivery composites on the rat prostate.
Yoshida M; Asano M; Kaetsu I; Yamanaka H; Nakai K; Yuasa H; Shida K
J Biomed Mater Res; 1985; 19(6):615-29. PubMed ID: 2416759
[TBL] [Abstract][Full Text] [Related]
6. The effect of oestradiol-3N-bis-(2-chloroethyl)carbamate-17beta-phosphate (estracyt) on the 5alpha-reductase in the rat ventral prostate.
Hoisaeter PA
Acta Endocrinol (Copenh); 1975 Sep; 80(1):188-98. PubMed ID: 1173982
[TBL] [Abstract][Full Text] [Related]
7. Effect of testosterone, dihydrotestosterone, estradiol, and prolactin on the weight and citric acid content of the lateral lobe of the rat prostate.
Walvoord DJ; Resnick MI; Grayhack JT
Invest Urol; 1976 Jul; 14(1):60-5. PubMed ID: 955852
[TBL] [Abstract][Full Text] [Related]
8. Sex differences in adrenocortical structure and function. IV. Effects of postpubertal gonadectomy and sex hormones on adrenal steroid 5alpha-reductase activity in the rat.
Malendowicz LK; Fichna P
Endokrinologie; 1978 Apr; 72(1):36-42. PubMed ID: 688982
[TBL] [Abstract][Full Text] [Related]
9. Chlropyrifos-methyl shows anti-androgenic activity without estrogenic activity in rats.
Kang HG; Jeong SH; Cho JH; Kim DG; Park JM; Cho MH
Toxicology; 2004 Jul; 199(2-3):219-30. PubMed ID: 15147795
[TBL] [Abstract][Full Text] [Related]
10. Testosterone-induced DNA synthesis in cultured rat ventral prostate: effects of estracyt and its derivatives.
Buchanan LJ; Riches AC
Br J Cancer; 1987 Jan; 55(1):47-51. PubMed ID: 3814475
[TBL] [Abstract][Full Text] [Related]
11. Effect of a steroidal alkylating agent (estramustine phosphate) in rat ventral prostate.
Høisaeter PA
Scand J Urol Nephrol Suppl; 1977; (46):1-72. PubMed ID: 279091
[No Abstract] [Full Text] [Related]
12. Comparative antitumor effects of hormonal ablation, estrogen agonist, estrogen cytotoxic derivative, and antiestrogen in the PAIII rat prostatic adenocarcinoma.
Neubauer BL; Best KL; Goode RL; Heiman ML; Hoover DM; Robertson DW; Sarosdy MF; Shaar CJ; Tanzer LR; Merriman RL
Cancer Res; 1992 Sep; 52(17):4663-71. PubMed ID: 1511432
[TBL] [Abstract][Full Text] [Related]
13. Selective increase in type II estrogen-binding sites in the dysplastic dorsolateral prostates of noble rats.
Ho SM; Yu M
Cancer Res; 1993 Feb; 53(3):528-32. PubMed ID: 7678774
[TBL] [Abstract][Full Text] [Related]
14. [Effect of anticancer agents on rat prostate. Evaluation of organ weight, histological finding and 5 alpha-reductase activities].
Takeda M; Hosaka M; Kitajima N; Noguchi K; Fujii H; Oshima H; Harada M
Hinyokika Kiyo; 1985 Jan; 31(1):71-80. PubMed ID: 2581430
[TBL] [Abstract][Full Text] [Related]
15. Effect of castration on the smooth muscle cells of the internal sex organs of the rat: influence of the smooth muscle on the sympathetic neurons innervating the vas deferens, seminal vesicle and coagulating gland.
Wakade AR; Garcia AG; Kirpekar SM
J Pharmacol Exp Ther; 1975 May; 193(2):424-34. PubMed ID: 1142099
[TBL] [Abstract][Full Text] [Related]
16. [Pharmacology and metabolism of a new therapeutic drug for prostatic cancer "Estracyt"].
Yamanaka H; Shida K
Gan To Kagaku Ryoho; 1984 Mar; 11(3):537-44. PubMed ID: 6422861
[TBL] [Abstract][Full Text] [Related]
17. Effect of cyproterone acetate on testis and accessory sex organs of male rat.
Kalla NR; Bhasin M
Acta Eur Fertil; 1983; 14(6):415-20. PubMed ID: 6232808
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of estrogenic and androgenic activity of butylated hydroxyanisole in immature female and castrated rats.
Kang HG; Jeong SH; Cho JH; Kim DG; Park JM; Cho MH
Toxicology; 2005 Sep; 213(1-2):147-56. PubMed ID: 16023279
[TBL] [Abstract][Full Text] [Related]
19. Antiprostatic effects of a nitrogen mustard of estriol.
Varkarakis MJ; Kirdani RY; Murphy GP; Sandberg AA
Proc Soc Exp Biol Med; 1975 Mar; 148(3):904-8. PubMed ID: 1129313
[TBL] [Abstract][Full Text] [Related]
20. [Fundamental investigation of estradiol-3N-bis-(2-chloroethyl) carbamate-17 beta-phosphate (Estracyt)-on the antiprostatic effect of this drug (author's transl)].
Yamanaka H; Koya J; Imai K; Nakai K; Yuasa H
Horumon To Rinsho; 1981 Apr; 29(4):477-85. PubMed ID: 7296919
[No Abstract] [Full Text] [Related]
[Next] [New Search]
